Combined administration of D-galactose and aluminium induces Alzheimerlike lesions in brain

Objective It has been reported that D -galactose ( D -gal) can model subacute aging, and aluminum (Al) acts as a neurotoxin, but combined effects of them have not been reported. The present work aimed to reveal the effect of combined administration of D -gal and Al in mice and compare the effect of...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience bulletin Vol. 27; no. 3; pp. 143 - 155
Main Authors Xiao, Fei, Li, Xiao-Guang, Zhang, Xiao-Yu, Hou, Jun-Dai, Lin, Lian-Feng, Gao, Qin, Luo, Huan-Min
Format Journal Article
LanguageEnglish
Published Heidelberg Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 01.06.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective It has been reported that D -galactose ( D -gal) can model subacute aging, and aluminum (Al) acts as a neurotoxin, but combined effects of them have not been reported. The present work aimed to reveal the effect of combined administration of D -gal and Al in mice and compare the effect of D -gal treatment with that of Al treatment. Methods Al was intragastrically administered and D -gal was subcutaneously injected into Kunming mice for 10 consecutive weeks. Learning and memory, cholinergic systems, as well as protein levels of amyloid β (Aβ) and hyperphosphorylated tau were determined using Morri water maze test, biochemical assays and immunohistochemical staining, respectively. Results The mice with combined treatment had obvious learning and memory deficits, and showed decreases in brain acetylcholine (ACh) level and in activities of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE). Formation of senile plaque (SP)-like and neurofibrillary tangle (NFT)-like structures was also observed. The behavioral and pathological changes persisted for at least 6 weeks after withdrawal of D -gal and Al. Conclusion Combined use of D -gal and Al is an effective way to establish the non-transgenic Alzheimer’s disease (AD) animal model, and is useful for studies of AD pathogenesis and therapeutic evaluation.
ISSN:1673-7067
1995-8218
DOI:10.1007/s12264-011-1028-2